IONS
Ionis Pharmaceuticals Inc
44.50$
+1.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +44.1% | +19.9% | -13.5% | +9.9% | +43.0% | +50.5% | -37.7% | -14.7% | -5.8% | -63.0% | +292.7% | +83.7% | +13.4% | -10.8% | -8.7% | +3.0% | +44.3% | +45.4% | +32.5% | +22.2% | +48.3% | +16.6% | +87.3% | -35.1% | +11.2% | -27.5% | +34.1% | -10.5% | +33.9% | |
| – | – | – | – | – | – | +11.0% | -69.1% | +34.5% | -14.2% | -72.1% | +89.9% | +247.9% | +25.2% | -25.9% | -59.0% | +991.6% | +16.1% | +31.4% | +33.3% | +6.8% | +8.8% | -99.5% | +119.8% | +200.0% | -9.7% | +30.2% | -35.3% | +22.8% | +42.7% | |
| – | +41.9% | +21.2% | -10.1% | +9.4% | +24.5% | +50.5% | -37.7% | -14.7% | -5.8% | -38.9% | +183.8% | +54.0% | +13.4% | -10.8% | -8.7% | -156.9% | – | – | – | – | +22,255.6% | +16.3% | +87.2% | -35.9% | +11.5% | -28.3% | +35.8% | -10.9% | +33.7% | |
| – | +22.3% | +11.3% | +6.8% | -14.1% | +46.9% | +48.2% | -5.7% | +1.3% | -30.4% | -2.3% | +15.0% | +14.9% | +26.5% | +7.8% | +8.4% | +0.7% | +16.1% | +31.4% | +33.3% | +6.8% | +8.8% | +10.7% | +12.4% | +14.8% | +20.2% | +29.5% | +8.0% | +0.2% | +1.6% | |
| – | – | – | – | – | -70.6% | -22.7% | +8.7% | +3.2% | -12.0% | +49.7% | +26.2% | -13.3% | +5.1% | -19.6% | +9.6% | -2.1% | +19.2% | +35.0% | +84.6% | +30.8% | +123.2% | +125.5% | +17.3% | +23.3% | -51.7% | -12.1% | +54.8% | +15.0% | +47.3% | |
| – | +23.5% | +13.1% | +8.2% | -12.7% | +38.4% | +31.8% | -1.5% | +24.4% | -39.4% | -17.7% | +14.0% | +31.8% | +24.0% | +5.2% | +8.5% | -92.6% | +1,489.7% | -89.9% | +84.6% | +957.0% | +23.0% | +36.4% | +14.2% | +18.1% | -6.7% | +18.5% | +15.1% | +3.2% | +12.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -297.7% | – | -147.0% | – | – | – | – | – | |
| – | – | – | – | – | – | +8.6% | +12.8% | +20.9% | -10.1% | -55.6% | -16.1% | -26.0% | +126.2% | +4.4% | +26.5% | +26.4% | -8.5% | +14.7% | +65.4% | +5.6% | +15.4% | +0.1% | +9.4% | -8.2% | -79.2% | -13.1% | +902.9% | +11.0% | +0.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -149.0% | – | – | – | – | – | |
| – | – | – | +53.3% | +52.1% | -63.7% | -23.6% | +162.4% | +220.3% | -61.1% | -202.6% | – | – | – | -97.1% | -88.0% | -82,909.1% | – | – | – | +688.7% | -303.8% | – | – | +620.5% | -100.2% | – | +175.4% | -119.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -139.5% | – | – | – | – | – | – | – | +79,015.9% | +7.4% | -265.6% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | -494.4% | – | – | – | – | – | – | – | – | -151.8% | – | -140.5% | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.